Consistently, BTNL2-KO LLC tumours had significantly fewer numbers of infiltrating γδT17 cells and MDSCs, and conversely higher numbers of infiltrating CD8+IFN-γ+ T cells, as compared to wild-type LLC tumours (Fig. 5e). The gene discussed is CD8A; the disease is neoplasm.